Search Results - "PRATT, Daniel S"

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement by Fix, Oren K., Hameed, Bilal, Fontana, Robert J., Kwok, Ryan M., McGuire, Brendan M., Mulligan, David C., Pratt, Daniel S., Russo, Mark W., Schilsky, Michael L., Verna, Elizabeth C., Loomba, Rohit, Cohen, David E., Bezerra, Jorge A., Reddy, K. Rajender, Chung, Raymond T.

“…Background and Aims Coronavirus disease 2019 (COVID‐19), the illness caused by the SARS‐CoV‐2 virus, is rapidly spreading throughout the world. Hospitals and…”
Get full text

Long‐term clinical impact and cost‐effectiveness of obeticholic acid for the treatment of primary biliary cholangitis by Samur, Sumeyye, Klebanoff, Matthew, Banken, Reiner, Pratt, Daniel S., Chapman, Rick, Ollendorf, Daniel A., Loos, Anne M., Corey, Kathleen, Hur, Chin, Chhatwal, Jagpreet

“…Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune liver disease that mainly affects middle‐aged women. Obeticholic acid (OCA), which was…”
Get full text

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis by Kowdley, Kris V., Bowlus, Christopher L., Levy, Cynthia, Mayo, Marlyn J., Pratt, Daniel S., Vuppalanchi, Raj, Younossi, Zobair M.

“…Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune liver disease that can progress to end-stage liver disease and its complications. A…”
Get full text

Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement by Allegretti, Andrew S, Frenk, Nathan E, Li, Darrick K, Seethapathy, Harish, Vela Parada, Xavier F, Long, Joshua, Endres, Paul, Pratt, Daniel S, Chung, Raymond T, Ganguli, Suvranu, Irani, Zubin, Yamada, Kei

“…The MELD score was developed to predict survival after transjugular intrahepatic portosystemic shunt (TIPS) placement. Given changes in practice patterns and…”
Get full text

Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients by E Frenk, Nathan, Bochnakova, Teodora, Ganguli, Suvranu, Mercaldo, Nathaniel, S Allegretti, Andrew, S Pratt, Daniel, Yamada, Kei

“…Maximally decreasing portal pressures with transjugular intrahepatic portosystemic shunt (TIPS) is associated with improved ascites control but also increased…”
Get full text

Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients by Pratt, Daniel S, Kaplan, Marshall M

“…Now that routine laboratory testing is automated and is frequently part of an annual checkup, physicians are often faced with the problem of a patient with one…”
Get full text

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis by Mueller, Tobias, Beutler, Claudia, Picó, Almudena Hurtado, Shibolet, Oren, Pratt, Daniel S., Pascher, Andreas, Neuhaus, Peter, Wiedenmann, Bertram, Berg, Thomas, Podolsky, Daniel K.

“…Background Pattern recognition receptors (PRRs) orchestrate the innate immune defence in human biliary epithelial cells (BECs). Tight control of PRR signalling…”
Get full text

Non–High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis by Corey, Kathleen E, Lai, Michelle, Gelrud, Louis G, Misdraji, Joseph, Barlow, Lydia L, Zheng, Hui, Andersson, Karin L, Thiim, Michael, Pratt, Daniel S, Chung, Raymond T

“…Background & Aims There are no clinically available biomarkers for nonalcoholic steatohepatitis (NASH); differentiating between steatosis and NASH requires…”
Get full text

Primary Biliary Cholangitis — A New Name and a New Treatment by Pratt, Daniel S

“…Primary biliary cholangitis, previously called primary biliary cirrhosis, is a cholestatic autoimmune liver disease that is marked by the progressive…”
Get full text

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial by Allegretti, Jessica R, Kassam, Zain, Carrellas, Madeline, Mullish, Benjamin H, Marchesi, Julian R, Pechlivanis, Alexandros, Smith, Mark, Gerardin, Ylaine, Timberlake, Sonia, Pratt, Daniel S, Korzenik, Joshua R

“…Primary sclerosing cholangitis (PSC) is a cholestatic liver disease with no effective medical therapies. A perturbation of the gut microbiota has been…”
Get full text

Liver transplantation outcomes for early‐stage hepatocellular carcinoma: Results of a multicenter study by Leung, Jessica Y., Zhu, Andrew X., Gordon, Fredric D., Pratt, Daniel S., Mithoefer, Abigail, Garrigan, Kathryn, Terella, Adam, Hertl, Martin, Cosimi, A. Benedict, Chung, Raymond T.

“…The incidence of hepatocellular carcinoma (HCC), a frequent and incurable complication of cirrhosis, continues to rise. Orthotopic liver transplantation (OLT)…”
Get full text

Painless jaundice with serial multi-organ dysfunction by Khosroshahi, Arezou, Dr, Stone, James R, MD, Pratt, Daniel S, MD, Deshpande, Vikram, MD, Stone, John H, MD

“…Autoimmune pancreatitis frequently mimics adeno carcinoma of the pancreas by causing painless jaundice, and has been diagnosed in 27% of patients undergoing…”
Get full text

Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases by Johncilla, Melanie, Misdraji, Joseph, Pratt, Daniel S, Agoston, Agoston T, Lauwers, Gregory Y, Srivastava, Amitabh, Doyle, Leona A

“…Ipilimumab is a monoclonal antibody that inhibits the CTLA4 receptor on cytotoxic T lymphocytes, resulting in immune-mediated tumor cell death. Ipilimumab is…”
Get full text

Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease by Hess, Anja, Gentile, Stefan D, Ben Saad, Amel, Rahman, Raza‐Ur, Habboub, Tim, Pratt, Daniel S, Mullen, Alan C

“…Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing cause of morbidity with limited treatment options. Thus, accurate in vitro…”
Get full text

The Role of Bezafibrate, a Peroxisome Proliferator‐Activated Receptor Alpha Agonist, in Patients With Primary Biliary Cholangitis by Pratt, Daniel S, Corey, Kathleen E, Malhi, Harmeet

Get full text

Intracardiac Echocardiography Guidance for Percutaneous Closure of Surgical Portocaval Shunt after Liver Transplant by Leon, David, Tanaka, Mari, Thabet, Ashraf, Bozorgzadeh, Adel, Pratt, Daniel S., Kalva, Sanjeeva P., Wu, Vincent

Get full text

Hepatic vascular remodelling in a patient with dyskeratosis congenita by Boyraz, Baris, Agarwal, Suneet, Pratt, Daniel S, Simoneau, Tregony, Bhan, Irun, Markmann, James F, Misdraji, Joseph

Get full text

In a tight spot by Przybyszewski, Eric M., Pratt, Daniel S.

“…1_5zesudt2 Kaltura…”
Get full text

IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material by Deshpande, Vikram, Sainani, Nisha I, Chung, Raymond T, Pratt, Daniel S, Mentha, Gilles, Rubbia-Brandt, Laura, Lauwers, Gregory Y

“…IgG4-associated cholangitis is a steroid-responsive hepatobiliary inflammatory condition associated with autoimmune pancreatitis that clinically and…”
Get full text

Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management by Bloom, Patricia P., Pasricha, Trisha S., Andersson, Karin L., Pratt, Daniel S., Hashemi, Nikroo, Bhan, Irun, Viveiros, Kathleen

“…Background Coronavirus disease 2019 (COVID-19) is associated with elevated liver biochemistries in approximately half of hospitalized patients, with many…”
Get full text